GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orgenesis Inc (FRA:45O) » Definitions » Investments And Advances

Orgenesis (FRA:45O) Investments And Advances : €0.01 Mil (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Orgenesis Investments And Advances?

Orgenesis's Investments And Advances for the quarter that ended in Jun. 2024 was €0.01 Mil.

Orgenesis's quarterly Investments And Advances stayed the same from Dec. 2023 (€0.01 Mil) to Mar. 2024 (€0.01 Mil) and stayed the same from Mar. 2024 (€0.01 Mil) to Jun. 2024 (€0.01 Mil).

Orgenesis's annual Investments And Advances declined from Dec. 2021 (€0.52 Mil) to Dec. 2022 (€0.04 Mil) and declined from Dec. 2022 (€0.04 Mil) to Dec. 2023 (€0.01 Mil).


Orgenesis Investments And Advances Historical Data

The historical data trend for Orgenesis's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orgenesis Investments And Advances Chart

Orgenesis Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Dec19 Dec20 Dec21 Dec22 Dec23
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.14 0.52 0.04 0.01

Orgenesis Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.06 21.09 0.01 0.01 0.01

Orgenesis Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Orgenesis Business Description

Traded in Other Exchanges
Address
20271 Goldenrod Lane, Germantown, MD, USA, 20876
Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Morgenesis and Therapies.

Orgenesis Headlines

No Headlines